ScinoPharm, Coland develop cancer generics in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 May, 2013
‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to ...Read more
VM202 trial completes patient administration
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2013
Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients f...Read more
Researchers find gene mutation to lower heart disease
Drug Discovery | News | By BioSpectrum Bureau | 1 Comment | 24 Apr, 2013
Singapore: By scouring the DNA of thousands of patients, researchers at Broad Institute, Massachusetts General Hospital,...Read more
EMA to review marketing plea for antipsychotic medication
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...Read more
Chipscreen gets SFDA nod after accelerated review
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 17 Apr, 2013
‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, r...Read more
FDA affirms superiority of Pradaxa over warfarin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
Singapore: US Food and Drug Administration has affirmed Boehringer Ingelheim's Pradaxa 150mg superior in reducing ischem...Read more
Sanofi withdraws diabetes drug NDA in the US
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2013
Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide i...Read more
Amgen to acquire Onyx for $10 bn cash
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...Read more
Effient trial by Daiichi, Lilly fails to meet primary endpoint
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...Read more
Astellas Pharma opens office in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2013
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...Read more
A*STAR, GSK develop medicines for emerging markets
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2013
Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-y...Read more
Aussie firm gets TGA approval for pancreatic cancer drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2014
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Good...Read more
Pharmaxis gets grants for fibrotic research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University o...Read more
Regenerative Therapy for heart failure enters Ph III Trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Belgian biotechnology company Cardio3 BioSciences (C3BS) has received authorization from the Belgian Federal ...Read more
Mesoblast to set up stem cell drug plant in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2014
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...Read more
Sanford-Burnham, Daiichi form new alliance
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 May, 2014
Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...Read more
Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013
Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and saf...Read more
Taiwan firm NCE to get priority review in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013
Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into ...Read more